Session Details
Symposium 4 Multidisciplinary Treatment Strategies for Anal Sphincter Preservation in Rectal Cancer: Balancing Functional Preservation and Oncologic Radicality
Sat. Nov 21, 2026 8:30 AM - 9:45 AM JST
Sat. Nov 21, 2026 11:30 PM - 12:45 AM UTC
Sat. Nov 21, 2026 11:30 PM - 12:45 AM UTC
Room 6 (1F 103)
司会：辻 晃仁（香川大学医学部臨床腫瘍学）、加藤 健志（独立行政法人国立病院機構大阪医療センター）
[SY4-1]Changes in Surgical Procedures and Postoperative Anal Function After the Introduction of Robot-Assisted Surgery for Low Rectal Cancer Within 5 cm of the Anal Verge
*Kazuma Hayashida1 (1. Department of Colorectal Surgery, National Cancer Center Japan)
[SY4-2]Outcomes of robot-assisted surgery for locally advanced rectal cancer: A strategy for balancing sphincter preservation and oncologic radicality
*Shoichi Manabe1 (1. Department of Colon and Rectal Surgery, Shizuoka Cancer Center Hospital)
[SY4-3]Postoperative complications and functional outcomes after sphincter-preserving surgery following preoperative chemoradiotherapy for rectal cancer
*Shigenobu Emoto1 (1. Department of Surgical Oncology, The University of Tokyo)
[SY4-4]Short-term outcomes of total neoadjuvant therapy for T2N0M0 Stage I rectal cancer: The AMBITION study
*Atsushi Hamabe1 (1. Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka)
[SY4-5]Strategic Total Neoadjuvant Therapy for Rectal Cancer: Disease-Based Regimen Selection and Clinical Outcomes
*Mikio Kawamura1,2,3 (1. Department of Gastrointestinal and Pediatric Surgery, Graduate School of Medicine, Mie University)
[SY4-6]Treatment outcomes of nonoperative management (NOM) after total neoadjuvant therapy (TNT) for rectal cancer in the ENSEMBLE-1 and ENSEMBLE-2 trials.
*Jun Watanabe1 (1. Department Colorectal Surgery, Kansai Medical University)
[SY4-7]Current Status and Future Perspectives of Immune Checkpoint Inhibitor Development for Resectable Locally Advanced Rectal Cancer
*Hideaki Bando1 (1. National Cancer Center Hospital East)